“FeelFull was purposefully created to help consumers naturally regulate appetite and stabilize metabolic function,” said Caroline Carralero, Founder & CEO of Daily Nouri.
Carralero told NutraIngredients-USA that the product is formulated with the “Slimbiome” blend of oligofructose, glucomannan and chromium picolinate from UK-based Optibiotix. Nouri has the U.S. exclusivity on the blend, she said.
The blend is supported by a clinical study published in the Journal of Functional Foods in 2020, which reported that four weeks of supplementation in overweight and obese women led to significant improvements in body weight, fat mass, waist and hip circumferences, and systolic blood pressure, when used in combination with calorie controlled diet. The study also found that the blend led to positive impacts on the composition of the gut microbiome and improvements in mood.
“This study suggests that the individual ingredients retained their efficacy when used in combination within the context of a calorie-controlled diet, resulting in an intervention that targeted directly weight loss but also gut microbiome diversity which may synergistically improve obesity related health outcomes,” wrote scientists from University of Roehampton (UK) and OptiBiotix Health Plc.
The research team has since followed this with a new study in healthy, normal weight individuals, which reportedly showed a 37% reduction in feelings of hunger and a 55% increase in feelings of fullness. The study will be published soon in the Journal of Nutrition, said Carralero.
“FeelFull not only helps people with feelings of fullness in support of weight management, but also supports gut microbiome diversity for consumers,” she said. “Good health starts with gut health, and FeelFull provides people with a supplemental tool to tackle their weight management goals by modulating the gut.”
Market opportunity
Almost 75% of Americans are classified as overweight or obese. The FDA approved semaglutide GLP-1 receptor agonists specifically for weight loss in 2021 and since then their availability and use have proliferated. According to KFF (formerly Kaiser Family Foundation), 12% of American adults report ever taking a glucagon-like peptide 1 (GLP-1) agonist medication, and currently about 6% of American adults are taking a GLP-1 medication (approximately 16 million Americans). Forty percent of users are taking them purely to lose weight.
However, use of the drugs is associated with a number of unwanted side effects. In addition, studies indicate that up to two-thirds of weight lost is typically regained within a year of discontinuing treatment. This has led to a significant opportunity for natural alternatives.
“People want simpler, more natural, science-backed alternatives to cost-prohibitive weight loss drugs that are unpleasant to take and may have deleterious long-term effects,” said Carralero. “FeelFull is precisely that–a clinically supported, flavorful, hassle-free drink mix that can easily be added to anyone’s daily weight management routine–without the physical or financial discomfort.”
The Daily Nouri FeelFull Prebiotic Lemonade Drink Mix with Chromium drink mix is formatted in portable stick packs and can be mixed with water, protein powders, or juices for easy consumption up to three times a day. The product is available via dailynouri.com and Amazon. Additional flavors and national retail launches are forthcoming, said the company.
